"APO(a) isoforms and LP(a) concentration in predicting risk for coronary artery disease: A study in men <55 years of age "

"APO(a) isoforms and LP(a) concentration in predicting risk for coronary artery disease: A study in men <55 years of age "

Lipoprotein (a) [Lp (a) is formed by assembly of LDL-particles and the carbohydrate rich protein, apolipoprotein (a) [apo (a)]. Elevated plasma Lp (a) levels are an independent predictor of the development of premature coronary artery disease (CAD), but is not clear whether the apo (a) isoform plays...

Full description

Bibliographic Details
Main Authors:	"Rashtchizadeh N, Javadi E, Doosti M, Mohagheghi A, Mahmoodi M "
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2000-11-01
Series:	Acta Medica Iranica
Subjects:	Lipoprotein(a) [LP(a)] Apolipoprotein(a) [apo(a)] Coronary artery disease (CAD) Isoform
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/1194.pdf&manuscript_id=1194

Similar Items

"APO(a) isoforms and LP(a) concentration in predicting risk for coronary artery disease: A study in men <55 years of age "
by: "Rashtchizadeh N, et al.
Published: (2000-12-01)

Apoprotein(a) isoforms and plasma LP(a) concentration in members of four families
by: Labudovik Danica, et al.
Published: (2008-01-01)

Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls
by: Benjie Ezeh, et al.
Published: (2003-08-01)

Association between high molecular weight apolipoprotein isoforms and lipoprotein levels in advanced chronic kidney disease and the effect of hemodialysis
by: J K Gambhir, et al.
Published: (2013-01-01)

Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates
by: Perry L. Colvin, et al.
Published: (1999-10-01)

The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients
by: Farzad Shidfar, et al.
Published: (2012-01-01)

The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab[S]
by: Byambaa Enkhmaa, et al.
Published: (2017-10-01)

Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
by: Corey A. Scipione, et al.
Published: (2015-12-01)

Production rate determines plasma concentration of large high density lipoprotein in non-human primates
by: Perry Colvin, et al.
Published: (1998-10-01)

Preprocedural Lp(a) level and ApoB/ApoA-Ι ratio and the risk for contrast-induced acute kidney injury in patients undergoing emergency PCI
by: Jun Tao, et al.
Published: (2021-10-01)

A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping
by: E. Anglés-Cano, et al.
Published: (1999-02-01)

ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Studys⃞
by: Erdembileg Anuurad, et al.
Published: (2007-03-01)

Size Matters: The Influence of Isoform Size on the Intracellular Processing of Apolipoprotein(a)
by: Han, KRISTINA
Published: (2009)

Small size apolipoprotein(a) isoforms enhance inflammatory and proteolytic potential of collagen-primed monocytes
by: Nadia Sabbah, et al.
Published: (2019-08-01)

Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects
by: Falcone Colomba, et al.
Published: (2003-12-01)

Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response
by: Veneracion G. Cabana, et al.
Published: (2003-04-01)

A comprehensive map of single-base polymorphisms in the hypervariable LPA kringle IV type 2 copy number variation region[S]
by: Stefan Coassin, et al.
Published: (2019-01-01)

A Specific Tubular ApoA-I Distribution Is Associated to FSGS Recurrence after Kidney Transplantation
by: Conxita Jacobs-Cachá, et al.
Published: (2021-05-01)

ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
by: Emanuel Voyiaziakis, et al.
Published: (1998-02-01)

Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies1[S]
by: Jere P. Segrest, et al.
Published: (2013-10-01)

Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II
by: Uli C. Broedl, et al.
Published: (2006-10-01)

Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study
by: Yan Zhang, et al.
Published: (2020-10-01)

Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype
by: Robert W. Mahley, et al.
Published: (2000-08-01)

Mechanisms of HDL deficiency in mice overexpressing human apoA-II
by: Josep Julve, et al.
Published: (2002-10-01)

Lipoprotein(a) and its Clinical Importance
by: farnaz zahedi avval, et al.
Published: (2020-03-01)

Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families[S]
by: Byambaa Enkhmaa, et al.
Published: (2019-09-01)

Effect of phospholipase A2 digestion on the conformation and lysine/fibrinogen binding properties of human lipoprotein[a]
by: Gunther M. Fless, et al.
Published: (1999-04-01)

Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer
by: Yu Sato, et al.
Published: (2020-09-01)

The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA2
by: Constantinos C. Tellis, et al.
Published: (2013-12-01)

Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis
by: O I Afanasievа, et al.
Published: (2016-09-01)

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]
by: Mohamad Navab, et al.
Published: (2011-06-01)

APOLIPROTEIN(A)-INDUCED APOPTOSIS IN VASCULAR ENDOTHELIAL CELLS
by: Tra, John
Published: (2011)

HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress
by: Xenia Moren, et al.
Published: (2008-06-01)

Molecular interactions between apoE and ABCA1
by: Larbi Krimbou, et al.
Published: (2004-05-01)

Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence- accelerated mouse
by: Makiko Umezawa, et al.
Published: (2003-04-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown, et al.
Published: (2008-01-01)

ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency*
by: Gery Gerritsen, et al.
Published: (2008-05-01)

Association of serum paraoxonase activity with lipid profile, APO-A and APO-B in subjects with different levels of HDL
by: Maryam Teimouri, et al.
Published: (2018-11-01)

APOE in the normal brain
by: Sarah A. Flowers, et al.
Published: (2020-03-01)

Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a]
by: Jill Rubin, et al.
Published: (2006-05-01)